Zygel FDA Approval Status
FDA Approved: No
Brand name: Zygel
Generic name: cannabidiol
Dosage form: Gel
Company: Zynerba Pharmaceuticals, Inc.
Treatment for: Behavioral Symptoms associated with Fragile X Syndrome
Zygel (cannabidiol gel) is a transdermal gel formulation of cannabidiol (CBD) in development for the treatment of behavioral symptoms associated with Fragile X Syndrome (FXS).
Development Timeline for Zygel
|May 6, 2019||Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel for the Treatment of Behavioral Symptoms Associated with Fragile X Syndrome (FXS)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.